Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Transdermal Drug Delivery Systems01:18

Transdermal Drug Delivery Systems

Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AI-based detection of neutrophil dysplasia: an accessible and sensitive model for MDS diagnosis from peripheral blood.

Annals of hematology·2025
Same author

Tracking the Evolution of Cutaneous Melanoma by Multiparameter Flow Sorting and Genomic Profiling.

International journal of molecular sciences·2025
Same author

Distinctive patterns of sequential platelet counts following blunt traumatic brain injury predict outcomes.

Brain injury·2024
Same author

Cell-Free DNA Genomic Profiling and Its Clinical Implementation in Advanced Prostate Cancer.

Cancers·2024
Same author

Exploring the intratumoral heterogeneity of DNA ploidy in prostate cancer.

Cancer reports (Hoboken, N.J.)·2023
Same author

Eastern Equine Encephalitis Virus: A Case Report and Brief Literature Review of Current Therapeutic and Preventative Strategies.

Vector borne and zoonotic diseases (Larchmont, N.Y.)·2023

Related Experiment Video

Updated: May 21, 2026

Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

Transcutaneous immunization with Intercell's vaccine delivery system.

Robert C Seid1, Jee Loon Look, Christian Ruiz

  • 1Intercell USA, 20 Firstfield Road, Suite 250, Gaithersburg, MD 20878, USA. rseid@intercell.com

Vaccine
|June 12, 2012
PubMed
Summary

Transcutaneous immunization (TCI) offers a needle-free vaccine delivery method using innovative skin patches. This technology advances vaccine stability and manufacturing, potentially improving global supply chains.

More Related Videos

Murine Model of Epicutaneously-Induced Immunomodulation
09:07

Murine Model of Epicutaneously-Induced Immunomodulation

Published on: June 24, 2025

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

Related Experiment Videos

Last Updated: May 21, 2026

Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

Murine Model of Epicutaneously-Induced Immunomodulation
09:07

Murine Model of Epicutaneously-Induced Immunomodulation

Published on: June 24, 2025

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

Area of Science:

  • Immunology
  • Dermatology
  • Biotechnology

Background:

  • Transcutaneous immunization (TCI) leverages skin immunity and advanced patch technology for alternative immunization.
  • TCI has shown promise in preclinical and clinical studies for various diseases.
  • Two TCI platforms, vaccine delivery patch (VDP) and vaccine enhancement patch (VEP), have been developed.

Purpose of the Study:

  • To detail advancements in TCI platforms, focusing on needle-free vaccine delivery and adjuvant enhancement.
  • To highlight technical breakthroughs in formulating and stabilizing dry vaccine patches.
  • To assess the potential of these innovations in improving vaccine manufacturing and supply chain efficiency.

Main Methods:

  • Development of needle-free vaccine delivery patch (VDP) and vaccine enhancement patch (VEP).
  • Utilization of mild skin abrasion to enhance patch application.
  • Implementation of microplate-based screening for excipient identification to stabilize vaccine formulations.
  • Application of nonwoven disc matrix-supported drying technology for stable dry patch production.

Main Results:

  • Successful formulation and stabilization of vaccines in a dry patch format.
  • Development of thermostable dry patches (VDP and VEP) through innovative drying technology.
  • Demonstrated potential for simplified manufacturing and reduced reliance on cold chain logistics.

Conclusions:

  • The developed TCI platforms (VDP and VEP) offer a viable needle-free immunization route.
  • Technical innovations in dry patch formulation and manufacturing enhance vaccine stability and accessibility.
  • These advancements promise to improve vaccine supply chain efficiency and reduce costs.